 - Patients who are currently receiving treatment with any medication which has a relative risk or prolonging the QTcF interval or inducing Torsades de Pointes as listed in Post-text supplement 2 and cannot be switched or discontinued to an alternative drug prior to commencing HSP990 dosing. 